Drug developer stocks rebounded over July and August, with 23 companies on the BioWorld Drug Developers Index posting gains and only seven declining. The two-month upswing marks a reversal from the ...
Race Oncology Ltd (ASX: RAC) shares have opened more than 20% higher after the company released positive cancer research data. The company's stock reached $3.74 in early trading, up 20.2%, marking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results